Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Defender Capital LLC.

Defender Capital LLC. reduced its position in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 7.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 39,085 shares of the biotechnology company's stock after selling 3,374 shares during the quarter. Axon Enterprise comprises approximately 8.5% of Defender Capital LLC.'s investment portfolio, making the stock its 5th biggest holding. Defender Capital LLC. owned about 0.05% of Axon Enterprise worth $23,229,000 at the end of the most recent quarter.

Several other hedge funds have also recently made changes to their positions in AXON. Public Sector Pension Investment Board boosted its holdings in Axon Enterprise by 19.2% in the third quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company's stock valued at $1,240,000 after purchasing an additional 500 shares during the last quarter. CIBC Asset Management Inc lifted its stake in Axon Enterprise by 9.2% in the 3rd quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company's stock valued at $4,227,000 after buying an additional 895 shares in the last quarter. Foundations Investment Advisors LLC acquired a new stake in Axon Enterprise in the 3rd quarter valued at about $221,000. Sequoia Financial Advisors LLC raised its holdings in Axon Enterprise by 4.9% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 1,727 shares of the biotechnology company's stock valued at $690,000 after acquiring an additional 81 shares during the last quarter. Finally, Axxcess Wealth Management LLC acquired a new stake in Axon Enterprise in the 3rd quarter valued at about $814,000. 79.08% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, Director Julie A. Cullivan sold 1,261 shares of the company's stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total transaction of $860,077.66. Following the transaction, the director now owns 2,392 shares of the company's stock, valued at approximately $1,631,487.52. This represents a 34.52 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Jeffrey C. Kunins sold 21,834 shares of the company's stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $593.88, for a total transaction of $12,966,775.92. Following the transaction, the insider now directly owns 154,394 shares of the company's stock, valued at $91,691,508.72. This trade represents a 12.39 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 50,545 shares of company stock valued at $30,721,337. Corporate insiders own 6.10% of the company's stock.

Analyst Upgrades and Downgrades

AXON has been the subject of a number of recent analyst reports. Needham & Company LLC raised their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a "buy" rating in a report on Friday, November 8th. JMP Securities raised their price target on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a "market outperform" rating in a research report on Thursday, October 31st. TD Cowen began coverage on shares of Axon Enterprise in a research report on Wednesday, January 8th. They set a "buy" rating and a $700.00 price objective for the company. The Goldman Sachs Group lifted their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a "buy" rating in a research report on Monday. Finally, Northland Securities lifted their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an "outperform" rating in a research note on Monday, November 11th. One equities research analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $524.85.

Axon Enterprise Price Performance

AXON stock traded up $10.66 during trading on Thursday, reaching $650.63. 271,503 shares of the company were exchanged, compared to its average volume of 551,141. The company has a market cap of $49.61 billion, a P/E ratio of 168.12, a PEG ratio of 6.09 and a beta of 1.04. Axon Enterprise, Inc. has a 52-week low of $247.04 and a 52-week high of $698.67. The stock's 50 day moving average price is $618.90 and its 200 day moving average price is $477.78. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.